2024/12/04 Abselion raises £6.6 million led by M Ventures to bring disruptive at-line protein analyser, Amperia, to market Series A financing highlights the potential impact of Abselion’s technology for life science research and bioprocess development.
2024/11/19 Concerto Biosciences Announces First Participant Dosed with Live Biotherapeutic ENS-002 in Phase 1 Trial for Atopic Dermatitis ENS-002 leverages a carefully selected trio of microbes to subdue virulent, inflammation-causing S. aureus, a core microbial driver of atopic dermatitis, offering a potential novel avenue for treatment.
2024/12/04 Abselion raises £6.6 million led by M Ventures to bring disruptive at-line protein analyser, Amperia, to market
2024/11/19 Concerto Biosciences Announces First Participant Dosed with Live Biotherapeutic ENS-002 in Phase 1 Trial for Atopic Dermatitis
2024/11/19 Nouscom Completes Patient Enrollment of Randomized Phase 2 Study Evaluating NOUS-209, an Off-the-Shelf Neoantigen Immunotherapy, in dMMR/MSI Metastatic Colorectal Cancer
2024/10/29 Kivu Bioscience Raises $92 Million Series A Led by Novo Holdings to Advance Next-Generation Antibody-Drug Conjugates
2024/10/04 Enara Bio raises $32.5 million Series B financing to advance first-in-class pipeline of TCR-based immunotherapies targeting novel Dark Antigens
2024/09/19 PictorLabs Raises $30 Million in Series B Funding to Accelerate AI-Powered Virtual Staining Technology
2024/09/10 Formo bags $61 million in Series B funding - launches the world’s first animal-free cheese made with Koji Protein
2024/09/03 Scrona AG and Electroninks Announce Collaboration in Materials and Process Development for Advanced Semiconductor Packaging
2024/09/03 Electroninks Launches World-First Copper MOD Ink to Revolutionize Advanced Semiconductor Packaging
2024/08/07 Anjuna Raises $25M Funding to Fuel Momentum and Expand Confidential Computing Offerings for AI
2024/07/16 M Ventures Participates in Asceneuron's $ 100M Series C Financing to Advance Groundbreaking Therapeutics in Neurodegenerative Diseases
2024/06/20 iOnctura announces EUR80 million Series B financing to progress pipeline through Phase II trials
2024/05/21 LabGenius raises £35 million led by M Ventures to further develop its ML-driven antibody discovery platform and progress a pipeline of assets towards the clinic
2024/04/11 Merck KGaA, Darmstadt, Germany’s Corporate Venture M Ventures Arm Backs Nucleai to Advance Its First-in-class Spatial AI Biomarker in Active Clinical Enrollment
2024/04/04 Biolinq Raises $58 Million to Advance Wearable Biosensors Through Pivotal Trial for Metabolic Health Using Precision Microsensor Technology
2024/03/06 Asceneuron Expands Scientific Advisory Board with World Leading Experts in Neurodegenerative Diseases
2024/01/16 DISCO Pharmaceuticals launches as the surfaceome company with EUR 20 Million in Seed Financing
2024/01/08 M Ventures portfolio company Calypso, a Merck KGaA, Darmstadt, Germany spin-out, enters into agreement to be acquired by Novartis